Evaluating photodynamic therapy versus brolucizumab as a second-line treatment for polypoidal choroidal vasculopathy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Evaluating photodynamic therapy versus brolucizumab as a second-line treatment for polypoidal choroidal vasculopathy ; volume:10 ; number:1 ; day:8 ; month:4 ; year:2024 ; pages:1-11 ; date:12.2024
International Journal of Retina and Vitreous ; 10, Heft 1 (8.4.2024), 1-11, 12.2024
- Creator
-
Funatsu, Ryoh
Terasaki, Hiroto
Mihara, Naohisa
Sonoda, Shozo
Shiihara, Hideki
Sakamoto, Taiji
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40942-024-00553-5
- URN
-
urn:nbn:de:101:1-2406240936546.469051738493
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Funatsu, Ryoh
- Terasaki, Hiroto
- Mihara, Naohisa
- Sonoda, Shozo
- Shiihara, Hideki
- Sakamoto, Taiji
- SpringerLink (Online service)
Other Objects (12)
1-year results of combined half-dose photodynamic therapy and ranibizumab for polypoidal choroidal vasculopathy
Photodynamic therapy versus anti-vascular endothelial growth factor agents for polypoidal choroidal vasculopathy: A meta-analysis
One-year outcome of combination therapy with intravitreal aflibercept and photodynamic therapy for polypoidal choroidal vasculopathy
Choroidal nevus and polypoidal vasculopathy: case series
One-Year Outcome of Aflibercept and Photodynamic Therapy in a Caucasian Patient with Polypoidal Choroidal Vasculopathy Refractory to Ranibizumab and Photodynamic Therapy
Comparing efficacy of reduced-fluence and standard-fluence photodynamic therapy in the treatment of polypoidal choroidal vasculopathy
Noninvasive multimodal imaging in diagnosing polypoidal choroidal vasculopathy
Clinical implications of pachyvessels in polypoidal choroidal vasculopathy
Polypoidal Choroidal Vasculopathy Associated with Optic Disc Coloboma
Responsiveness of eyes with polypoidal choroidal vasculopathy with choroidal hyperpermeability to intravitreal ranibizumab
Real-world outcomes of combined therapy of photodynamic therapy with anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy
Comparison of the effects of photodynamic therapy, intravitreal ranibizumab and combination for polypoidal choroidal vasculopathy under 1 + PRN regimen
1-year results of combined half-dose photodynamic therapy and ranibizumab for polypoidal choroidal vasculopathy
Photodynamic therapy versus anti-vascular endothelial growth factor agents for polypoidal choroidal vasculopathy: A meta-analysis
One-year outcome of combination therapy with intravitreal aflibercept and photodynamic therapy for polypoidal choroidal vasculopathy
Choroidal nevus and polypoidal vasculopathy: case series
One-Year Outcome of Aflibercept and Photodynamic Therapy in a Caucasian Patient with Polypoidal Choroidal Vasculopathy Refractory to Ranibizumab and Photodynamic Therapy
Comparing efficacy of reduced-fluence and standard-fluence photodynamic therapy in the treatment of polypoidal choroidal vasculopathy
Noninvasive multimodal imaging in diagnosing polypoidal choroidal vasculopathy
Clinical implications of pachyvessels in polypoidal choroidal vasculopathy
Polypoidal Choroidal Vasculopathy Associated with Optic Disc Coloboma
Responsiveness of eyes with polypoidal choroidal vasculopathy with choroidal hyperpermeability to intravitreal ranibizumab
Real-world outcomes of combined therapy of photodynamic therapy with anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy
Comparison of the effects of photodynamic therapy, intravitreal ranibizumab and combination for polypoidal choroidal vasculopathy under 1 + PRN regimen
1-year results of combined half-dose photodynamic therapy and ranibizumab for polypoidal choroidal vasculopathy
Photodynamic therapy versus anti-vascular endothelial growth factor agents for polypoidal choroidal vasculopathy: A meta-analysis
One-year outcome of combination therapy with intravitreal aflibercept and photodynamic therapy for polypoidal choroidal vasculopathy
Choroidal nevus and polypoidal vasculopathy: case series
One-Year Outcome of Aflibercept and Photodynamic Therapy in a Caucasian Patient with Polypoidal Choroidal Vasculopathy Refractory to Ranibizumab and Photodynamic Therapy
Comparing efficacy of reduced-fluence and standard-fluence photodynamic therapy in the treatment of polypoidal choroidal vasculopathy
Noninvasive multimodal imaging in diagnosing polypoidal choroidal vasculopathy
Clinical implications of pachyvessels in polypoidal choroidal vasculopathy
Polypoidal Choroidal Vasculopathy Associated with Optic Disc Coloboma
Responsiveness of eyes with polypoidal choroidal vasculopathy with choroidal hyperpermeability to intravitreal ranibizumab
Real-world outcomes of combined therapy of photodynamic therapy with anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy